Figure 6 | Experimental & Molecular Medicine

Figure 6

From: Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells

Figure 6

Chemokine receptor expression is regulated by rhamnogalacturonan II (RG-II) in bone marrow-derived dendritic cells (BMDCs). (a) Effect of RG-II on CCR7 (C-C motif chemokine receptor 7) expression. On day 6, BMDCs were incubated with RG-II (0.5 mg ml−1) or lipopolysaccharide (LPS; 200 ng ml−1) for 24 h. On day 7, phycoerythrin (PE)-conjugated CCR7 cells were analyzed by flow cytometry. Cells were gated on CD11c+. (b) Effect of RG-II on CCR1 and CCR7 mRNA expression. On day 6, BMDCs were incubated with RG-II (0.5 or 1 mg ml−1) or were incubated with or without LPS (200 ng ml−1) for 24 h. Quantitative mRNA expression was measured as described in the Materials and Methods section. * And ** indicate significant differences at P<0.05 and P<0.01, respectively, compared with unstimulated cells. The results shown are representative of three independent experiments.

Back to article page